Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.66 USD | -3.20% | +0.15% | -8.05% |
May. 23 | Supernus Pharmaceuticals Reports 'Clinical Utility' From Epilepsy Treatment Study | MT |
May. 23 | Transcript : Supernus Pharmaceuticals, Inc. - Special Call |